in Re Omeprazole Patent Litigation… v. MYLAN LABORATORIES INC. (now known as Mylan Inc.), MYLAN PHARMACEUTICALS INC.,…

NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
IN RE OMEPRAZOLE PATENT LITIGATION
--------------------------------------------------------------------------
ASTRAZENECA AB, AKTIEBOLAGET HASSLE,
KBI-E, INC., KBI, INC., AND ASTRAZENECA LP,
Plaintiffs-Appellees,
v.
MYLAN LABORATORIES INC. (now known as
Mylan Inc.), MYLAN PHARMACEUTICALS INC.,
LABORATORIOS DR. ESTEVE, S.A. and ESTEVE
QUIMICA, S.A.,
Defendants-Appellants.
____________________
2010-1414
______________________
Appeal from the United States District Court for the
Southern District of New York in Nos. 00-CV-6749, 03-
CV-6057, M-21-81, and MDL no. 1291, Judge Barbara S.
Jones.
______________________
JUDGMENT
______________________
ERROL B. TAYLOR, Milbank, Tweed, Hadley & McCloy
LLP, of New York, New York, argued for plaintiffs-
appellees. With him on the brief were FREDRICK M.
ZULLOW, JOHN M. G RIEM, JR., and CHRISTOPHER J.
G ASPAR.

-- 1 of 2 --

JAMES H. WALLACE, JR., Wiley Rein, LLP, of
Washington, DC, argued for defendants-appellants. With
him on the brief were MARK A. PACELLA and BRIAN H.
PANDYA.
______________________
THIS CAUSE having been heard and considered, it is
O RDERED and ADJUDGED :
PER CURIAM (RADER, Chief Judge, M OORE and
O’M ALLEY, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
March 8, 2011 /s/ Jan Horbaly
Date Jan Horbaly
Clerk

-- 2 of 2 --